Next Article in Journal
Metformin Decreases Risk of Tuberculosis Infection in Type 2 Diabetes Patients
Previous Article in Journal
Correction of Hyponatremia May Be a Treatment Stratification Biomarker: A Two-Stage Systematic Review and Meta-Analysis
Article Menu
Issue 9 (September) cover image

Export Article

Open AccessArticle
J. Clin. Med. 2018, 7(9), 263; https://doi.org/10.3390/jcm7090263

Can Intradetrusor OnabotulinumtoxinA Injections Alter Heart Function in Patients with Cardiac Arrhythmia?

1
Second Department of Gynaecology, Medical University of Lublin, ul. Jaczewskiego 8, 20-954 Lublin, Poland
2
Department of Urology, SPZOZ Staszow, 11 Listopada 78, Staszów 28-200, Poland
3
Department of Cardiology, Medical University of Lublin, ul. Jaczewskiego 8, 20-954 Lublin, Poland
4
Department of Paediatric Pulmonology and Rheumatology, Medical University of Lublin, ul. Chodźki 1, 20-093 Lublin, Poland
These authors contributed equally to this work.
*
Authors to whom correspondence should be addressed.
Received: 21 August 2018 / Revised: 2 September 2018 / Accepted: 7 September 2018 / Published: 9 September 2018
Full-Text   |   PDF [881 KB, uploaded 9 September 2018]   |  

Abstract

The prevalence of overactive bladder (OAB) increases with age and can be associated with other co-morbidities, such as cardiac arrhythmia. Unfortunately, commonly used anticholinergic drugs for OAB can affect the cardiovascular system, leading to tachycardia. However, there are no data, which consider the influence of intradetrusor onabotulinumtoxinA injections on heart function in idiopathic OAB patients. The aim of the present study was to evaluate the influence of intradetrusor onabotulinumtoxinA injections on electrocardiogram (ECG) parameters. Additionally, changes in ECG were analyzed in OAB patients without cardiac arrhythmia. Thirty-one patients with cardiac arrhythmia and 31 participants without irregular heart rate (HR) completed the study. ECG measurements were performed in supine positions 2 h before onabotulinumtoxinA injections, 1 h after treatment, and at 2 weeks of follow-up. At week 6, a phone-call survey was conducted to collect data about adverse events. OnabotulinumtoxinA injections were performed with rigid cystoscopy under local anesthesia. We did not observe any clinically significant changes in the analyzed ECG parameters between consecutive measurements. While a slight increase of HR was observed in patients without cardiac arrhythmia, it remained within normal range. Intravesical onabotulinumtoxinA injections are, hence, safe for female patients with cardiac arrhythmia and do not significantly influence changes in ECG. View Full-Text
Keywords: cardiac arrhythmia; overactive bladder; onabotulinumtoxinA injections; botulinum toxin A; urinary incontinence cardiac arrhythmia; overactive bladder; onabotulinumtoxinA injections; botulinum toxin A; urinary incontinence
Figures

Figure 1

This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. (CC BY 4.0).
SciFeed

Share & Cite This Article

MDPI and ACS Style

Miotla, P.; Olejniczak, P.; Futyma, K.; Wrobel, A.; Tomaszewski, M.; Bogusiewicz, M.; Wawrysiuk, S.; Markut-Miotla, E.; Rechberger, T. Can Intradetrusor OnabotulinumtoxinA Injections Alter Heart Function in Patients with Cardiac Arrhythmia? J. Clin. Med. 2018, 7, 263.

Show more citation formats Show less citations formats

Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Related Articles

Article Metrics

Article Access Statistics

1

Comments

[Return to top]
J. Clin. Med. EISSN 2077-0383 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert
Back to Top